National Comprehensive Cancer Network



About NCCN

Hodgkin Lymphoma Panel - Disclosures as of 4/17/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Ranjana H. Advani, MD

Genentech, Inc.;
Jannsen Pharmaceutica Products, LP;
Millennium Pharmaceuticals, Inc.;
Allos Therapeutics;
Seattle Genetics;
Pharmacyclics

Eisai Inc.;
Genentech, Inc.;
Millennium Pharmaceuticals, Inc.;
Seattle Genetics

None

None

7/17/2013

Weiyun Z. Ai, MD

None

None

None

None

1/20/2014

Richard F. Ambinder, MD, PhD

None

None

None

None

12/11/2013

Patricia Aoun, MD, MPH

None

None

None

None

3/26/2013

Celeste M. Bello, MD, MSPH

Seattle Genetics

Seattle Genetics;
Spectrum Pharmaceuticals

None

None

8/10/2012

Cecil M. Benitez, BS

None

None

None

None

10/12/2013

Philip J. Bierman, MD

Otsuka Pharmaceuticals;
Seattle Genetics

None

None

None

5/1/2013

Kristie A. Blum, MD

AstraZeneca Pharmaceuticals LP;
Celgene Corporation;
Jannsen Pharmaceutica Products, LP;
Millennium Pharmaceuticals, Inc.;
Novartis Pharmaceuticals Corporation;
Pharmacyclics

None

None

None

8/30/2013

Jennifer Burns

None

None

None

None

8/13/2013

Robert Chen, MD

Seattle Genetics

Millennium Pharmaceuticals, Inc.;
Seattle Genetics

None

None

9/5/2013

Bouthaina Dabaja, MD

None

None

None

None

4/14/2014

Richard I. Fisher, MD

None

Boehringer Ingelheim GmbH;
Bio Linx;
Hoffman LaRoche;
Micromet;
Pfizer Inc.

None

None

3/19/2013

Andres Forero, MD

Abbott Laboratories;
Biogen Idec;
Celgene Corporation;
Daiichi- Sankyo Co.;
Eisai Inc.;
Eli Lilly and Company;
Genentech, Inc.;
BioCryst;
Immunomedics;
Seattle Genetics

None

None

None

5/5/2012

Lauren Gallagher, RPh, PhD

None

None

None

None

6/18/2013

Leo I. Gordon, MD

CureTech Ltd.;
Genentech, Inc.

CureTech Ltd.

None

CureTech Ltd.

6/20/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

Francisco Hernandez-Ilizaliturri, MD

None

Amgen Inc.;
Millennium Pharmaceuticals, Inc.;
Seattle Genetics

None

None

9/5/2013

Ephraim P. Hochberg, MD

None

Biogen Idec;
Genentech, Inc.;
Proventys/NCCN;
Sigma-Tau Pharmaceuticals, Inc.

None

Seatle Genetics

6/14/2013

Richard T. Hoppe, MD

None

Clarient

None

Takeda Pharmaceuticals North America, Inc.

9/10/2013

Jiayi Huang, MD

None

None

None

None

6/24/2013

David G. Maloney, MD, PhD

Seattle Genetics, Inc.

None

None

Genentech, Inc.;
F. Hoffmann-La Roche Ltd.

9/6/2013

Peter Mauch, MD

None

None

None

None

2/28/2013

Joan S. McClure, MS

None

None

None

None

8/13/2013

Monika Metzger, MD

Seattle Genetics

General Electric

None

None

1/13/2014

Joseph O. Moore, MD

ARIAD Pharmaceuticals, Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

ARIAD Pharmaceuticals, Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

1/15/2014

David Morgan, MD

None

None

None

None

9/12/2013

Craig H. Moskowitz, MD

Plexxicon;
seattle genetics;
Roche Laboratories, Inc.

GlaxoSmithKline;
GlaxoSmithKline;
Jannsen Pharmaceutica Products, LP;
Seattle Genetics;
Seattle Genetics;
Roche Laboratories, Inc.;
Roche Laboratories, Inc.

None

None

1/17/2014

Carolyn Mulroney, MD

None

None

None

None

9/26/2013

Matthew Poppe, MD

None

None

None

None

8/30/2013

Rachel Rabinovitch, MD

       

Pending

Hema Sundar, PhD

None

None

None

None

1/13/2014

Sarika Trikha

None

None

None

None

8/13/2013

Christina Tsien, MD

None

None

None

None

3/5/2013

Jane N. Winter, MD

None

Jannsen Pharmaceutica Products, LP;
sanofi-aventis U.S.

None

None

9/10/2013

Joachim Yahalom, MD

None

None

None

None

10/17/2013